UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis

Journal of clinical apheresis, 2012, Vol.27 (2), p.99-105

2012

Volltextzugriff (PDF)

Structural diversity and organization of three gene families for Kunitz-type enzyme inhibitors from potato tubers (Solanum tuberosum L.)

Molecular genetics and genomics : MGG, 2003-07, Vol.269 (4), p.526-534

2003

Volltextzugriff (PDF)

Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy

HNO, 2010-05, Vol.58 (5), p.445-451

2010

Volltextzugriff (PDF)

Members of the Kunitz-type protease inhibitor gene family of potato inhibit soluble tuber invertase in vitro

Potato research, 2002-01, Vol.45 (2-4), p.163-176

2002

Volltextzugriff (PDF)

Rheopherese bei rezidivierendem Hörsturz: Therapieoption für Patienten nach erfolgloser Infusionstherapie

HNO, 2010, Vol.58 (5), p.445-451

2010

Volltextzugriff (PDF)

Quality of life in patients with idiopathic sudden hearing loss: comparison of different therapies using the Medical Outcome Short Form (36) Health Survey questionnaire

Otology & neurotology, 2008-09, Vol.29 (6), p.769

2008

Volltextzugriff (PDF)

Determination of BOD-values of starch-containing waste water by a BOD-biosensor

Biosensors & bioelectronics, 1998-11, Vol.13 (10), p.1083-1090

1998

Volltextzugriff (PDF)

Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis

Journal of Clinical Apheresis, 2012, Vol.27 (2), p.99-105

2012

Volltextzugriff (PDF)

Mix-a-lot: Impulse der Mixed-Methods-Forschung für die Empirische Kulturwissenschaft

Zeitschrift für Empirische Kulturwissenschaft, 2024-06, Vol.2024 (1), p.62-89

Heibges, Maren

2024

Volltextzugriff (PDF)

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study

Circulation (New York, N.Y.), 2013-12, Vol.128 (24), p.2567-2576

2013

Volltextzugriff (PDF)

"You Never Get a Second Chance": First Impressions of Physicians Depend on Their Body Posture and Gender

Frontiers in psychology, 2022-03, Vol.13, p.836157-836157

2022

Volltextzugriff (PDF)

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Arteriosclerosis, thrombosis, and vascular biology, 2016-09, Vol.36 (9), p.2019

2016

Volltextzugriff (PDF)

Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics

British journal of clinical pharmacology, 2020-10, Vol.86 (10), p.1989-1999

2020

Volltextzugriff (PDF)

Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW)

JMIR formative research, 2023-04, Vol.7, p.e41179-e41179

2023

Volltextzugriff (PDF)

Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial

Journal of exposure science & environmental epidemiology, 2017-07, Vol.27 (4), p.444-450

2017

Volltextzugriff (PDF)

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis

The American journal of cardiology, 2020-12, Vol.136, p.38-48

2020

Volltextzugriff (PDF)

(K)information: Gamete Donation and Kinship Knowledge in Germany and Britain

Klotz, Maren

1, 2014

Volltextzugriff (PDF)

Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of Germany

Biomedicine hub, 2022, Vol.7 (1), p.36-41

2022

Volltextzugriff (PDF)

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis

Journal of clinical apheresis, 2020-06, Vol.35 (3), p.163-171

2020

Volltextzugriff (PDF)

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

Pediatric nephrology (Berlin, West), 2018-07, Vol.33 (7), p.1199-1208

2018

Volltextzugriff (PDF)

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

Journal of clinical apheresis, 2019-08, Vol.34 (4), p.423-433

2019

Volltextzugriff (PDF)

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

European archives of oto-rhino-laryngology, 2009-07, Vol.266 (7), p.943-953

2009

Volltextzugriff (PDF)

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

Therapeutic apheresis and dialysis, 2010-06, Vol.14 (3), p.276-286

2010

Volltextzugriff (PDF)

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Clinical research in cardiology supplements, 2017-03, Vol.12 (Suppl 1), p.38-43

2017

Volltextzugriff (PDF)

Lipoprotein(a) and mortality—a high risk relationship

Clinical research in cardiology supplements, 2019-04, Vol.14 (Suppl 1), p.13-19

2019

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(40)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis

Structural diversity and organization of three gene families for Kunitz-type enzyme inhibitors from potato tubers (Solanum tuberosum L.)

Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy

Members of the Kunitz-type protease inhibitor gene family of potato inhibit soluble tuber invertase in vitro

Rheopherese bei rezidivierendem Hörsturz: Therapieoption für Patienten nach erfolgloser Infusionstherapie

Quality of life in patients with idiopathic sudden hearing loss: comparison of different therapies using the Medical Outcome Short Form (36) Health Survey questionnaire

Determination of BOD-values of starch-containing waste water by a BOD-biosensor

Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis

Mix-a-lot: Impulse der Mixed-Methods-Forschung für die Empirische Kulturwissenschaft

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study

"You Never Get a Second Chance": First Impressions of Physicians Depend on Their Body Posture and Gender

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics

Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW)

Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis

(K)information: Gamete Donation and Kinship Knowledge in Germany and Britain

Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of Germany

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Lipoprotein(a) and mortality—a high risk relationship

Suchergebnisse filtern